Request: CSI was tasked with sourcing a vast quantity of Venetoclax and Azacitidine for a large pharmaceutical company's global study on Acute Myeloid Leukaemia, covering 17 countries in 3 continents. Challenge: The client needed to enroll patients within an extremely short timeframe of 6-months. Additionally, due to the global nature of the study, they also required Certificates of Analysis (CoA), making the feasibility of the request extra challenging. Solution: Leveragi